Results

Total Results: 2,228 records

Showing results for "disease".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/dcis-mri-utilization_research.pdf
    August 01, 2012 - increased dramatically from 2002 to 2007 for both women with DCIS (<1% to 12.9%) and with invasive disease … Specifically, we included International Classification of Diseases for Oncology, Third Edition (ICD-O … Among women with invasive cancer, rates of MRI use de- creased with higher grade disease. … The increase was observed for both women with DCIS and early invasive disease. … ) received more MRIs prior to surgery than those with lower risk disease.
  2. effectivehealthcare.ahrq.gov/products/lysosomal-storage-diseases-therapies/technical-brief
  3. effectivehealthcare.ahrq.gov/sites/default/files/ch_6-user-guide-to-ocer_130129.pdf
    October 30, 2012 - such as in cancer or H5N1 influenza; or to manage or reduce the burden of chronic diseases including … diabetes, psoriasis, Parkinson’s disease, and depression. … only six items.34 In contrast, other popular measures focus on symptoms that are affected by many diseases … Statistical validation of intermediate endpoints for chronic diseases. … The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19-appendix-table-B-1.xlsx
    January 24, 2022 - : 3 (8.6) Cardiovascular disease: 4 (11.4) CKD: 1 (2.9) Chronic lung disease: 3 (8.6) CMIA ELISA Abbott … ) Pulmonary disease: 2 (12.5) Heart disease: 2 (12.5) CLIA IgG, IgM ManglumiTM 2019 nCovIgM and the MaglumiTM … controlled cohort 10 HIV Adult COVID-19 patients who were hospitalized in the Department of Infectious Diseases … 2020 - 11/30/2020 COVID-19 patients >18 yrs old who were hospitalized in the Department of Infectious Diseases … patients) The Transplant Institute, Sahlgrenska University Hospital, and the Department of Infectious Diseases
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/restless-legs_research-protocol.pdf
    December 16, 2011 - and Objectives for the Systematic Review Overview Restless legs syndrome (RLS) or Willis-Ekbom disease … If the disease progresses, symptoms may occur earlier in the day and intensify even further at night … are used to assess disease severity and treatment- induced changes in disease status. … Yet, the disease is chronic, often requiring life-long treatment. … and definition of clinically significant change in disease status used in individual studies.
  6. Dyspnea DEcIDE (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/dyspnea_research.pdf
    April 01, 2010 - requires valid, reliable, and responsive measures of the care provided to patients across settings and diseases … review of over 5000 titles in Western literature for quality measures of symptom management across diseases … care measure set.17 The dyspnea measure evaluates the proportion of patients with advanced chronic diseases … VAS were felt by panelists to be appropriate for clinical dyspnea assessment in chronic progressive diseases … Descriptors of breathlessness in cardiorespiratory diseases.
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_research-protocol.pdf
    March 09, 2010 - arthritis (JIA), formerly known as juvenile rheumatoid arthritis, is the most common rheumatologic disease … with more destructive joint disease … Evaluating changes in JIA disease status can be challenging. … First, these measures evaluate relative and not absolute changes in disease progression. … Effects of Omega-3 Fatty Acids on Cardiovascular Disease.
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_appendixes.pdf
    April 01, 2005 - Imaging test: Laboratory test: Clinical exam test: Demographics: Concurrent diseases … Survival in renal vascular disease. … Surgery for renovascular diseases: a single-center experience in revascularizing renal artery stenosis … HTN and CKD • Populations had ≥60% to ≥80% stenosis • Populations had unilateral and bilateral diseases … that bilateral versus unilateral disease did not predict progressive kidney disease
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0277_03-10-2008.pdf
    January 01, 2008 - HSCTs are used to treat both malignant and non-malignant diseases in children. … HSCT is associated with high morbidity and mortality in all ages and all diseases. … Factors that impact the appropriateness and success of any HSCT include the stage and/or severity of the disease … ), there is a large body of literature regarding HSCT across many diseases. … The diseases covered in the AHRQ review will be defined during the refinement phase.
  10. effectivehealthcare.ahrq.gov/sites/default/files/clinical-pathway-methods-report-appendix-k.pdf
    February 01, 2018 - Australasian Society of Infectious Diseases 20164 Oral antibiotic treatment – nonsevere disease … ; FMT: Fecal microbiota transplantation; ID: infectious disease; SHEA/IDSA: Infectious Diseases Society … Debast SB, Bauer MP, Kuijper EJ, Committee Centre for Infectious Diseases. … Definitions of Disease Severity by Guideline Organization Definitions Infectious Diseases Society of … Australasian Society of Infectious Diseases 20164 CDI: A + (B or C) A.
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/arthritis-psoriatric_executive.pdf
    April 01, 2012 - The condition is associated with the skin disease psoriasis, but not all people with psoriasis will … Additionally, PsA may predate the development of skin disease, leading to some diagnostic uncertainty … Available therapies for PsA include corticosteroids, oral disease-modifying antirheumatic drugs or … Analytic framework for treatment for psoriatic arthritis DMARDS = disease-modifying antirheumatic … * American College of Rheumatology measure of disease activity: response scores based on 20, 50, or
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-update_research-protocol.pdf
    May 07, 2010 - extensively for treatment of hypertension, heart failure, myocardial infarction, diabetes, and renal diseasedisease or events, symptomatic coronary artery disease, end-stage renal disease, quality of life, … , and cerebrovascular disease- specific) o Morbidity (cardiac events [MI], heart failure, cerebral … vascular disease or events [including stroke], symptomatic coronary artery disease, end-stage renal … disease, peripheral vascular disease [as clinically manifest, not markers of], quality of life)
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/plasma-cell-dyscrasias-sflc-assay-future_research.pdf
    September 01, 2012 - monitoring.3,6 The SFLC assay may also be the only means of detecting a disease marker in some disease … o Studies of only patients with disease reflects the extreme end of the spectrum of disease severity … 1 *Polyclonal gammopathy is seen in a diverse range of inflammatory and neoplastic diseases where clonal … Poor, since PCD is a rare disease. … 1 *Polyclonal gammopathy is seen in a diverse range of inflammatory and neoplastic diseases where clonal
  14. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-2007_executive.pdf
    January 01, 2007 - extensively for treatment of hypertension, heart failure, myocardial infarction, diabetes, and renal diseasedisease-specific mortality) and morbidity (cardiac events [myocardial infarction], heart failure, cerebral … vascular disease or events [including stroke], symptomatic coronary artery disease, end stage renal … disease, peripheral vascular disease, and quality of life). 4Safety outcomes considered were overall … (either based on creatinine, GFR, or renal disease) proteinuria).
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-future_research.pdf
    March 01, 2012 - , CHF with or without preserved LV function, diabetes, peripheral arterial disease, chronic kidney diseasedisease, or chronic kidney disease) on ACEI/ARB/DRI effectiveness or harms in patients with hypertension … disease, prior coronary revascularization; single- vs. multi-vessel coronary artery disease) on ACE-I … , peripheral vascular disease, diabetes, chronic kidney disease, or congestive heart failure. … ICD-9 (International Classification of Diseases, Ninth Revision) and CPT (Current Procedural Terminology
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/psoriasis-chronic_research-protocol.pdf
    January 10, 2012 - duration, baseline disease severity, affected BSA, disease location, number and type of previous treatments … oral solution, intra- lesional) ‡ Approved for use in endocrine and rheumatic disorders; collagen diseases … ; dermatologic diseases including pemphigus, bullous dermatitis herpetiformis, severe erythema multiforme … mycosis fungoides, severe psoriasis, and severe seborrheic dermatitis; allergic states; ophthalmic diseases … ; respiratory disease; hematologic disorders; neoplastic disease; edematous states; gastrointestinal
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0334_08-04-2010.pdf
    January 01, 2010 - events (e.g., ischemic stroke, symptomatic peripheral arterial disease), or (3) undergoing percutaneous … s): (1) Patients with acute coronary syndrome, (2) patients who have suffered other cardiovascular disease-related … events (e.g., ischemic stroke, symptomatic peripheral arterial disease), or (3) patients undergoing … Outcome(s): Recurrent ischemic events, stent thromboses, cardiovascular disease- related morbidity and …  While clopidogrel may decrease morbidity and mortality associated with several cardiovascular diseases
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/dementia-databases-methods_research.pdf
    May 01, 2008 - Lewy bodies, and mixed forms of dementia. 1 ADRD are prevalent, devastating, and costly diseases affecting … Alzheimer’s disease was defined using the 331 code. … Rates of use were highest among those with a claim for Alzheimer’s Disease. … Alzheimer disease in the US population: Prevalence estimates using the 2000 census. … The accuracy of medicare claims data in identifying Alzheimer's disease.
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-hospitalizations_research.pdf
    October 01, 2008 - selected common (pneumonia and congestive heart failure) and less frequent (sepsis, invasive pneumococcal diseases … serious renal (patients on hemodialysis), liver (hepatic coma and hepatorenal syndrome), or respiratory diseases … definitions for community-acquired pneumonia, sepsis, congestive heart failure, invasive pneumococcal diseases … Assessing the ability of our definitions to identify rare conditions, such as invasive pneumococcal diseases … This PPV depends on disease prevalence and the specificity of the definitions7, and when disease prevalence
  20. effectivehealthcare.ahrq.gov/products/copd-management/research

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: